Synjardy 12.5 mg

SYNJARDY 12.5 MG tablets combine empagliflozin and metformin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

SYNJARDY 12.5 MG tablets are used to help manage type 2 diabetes in adults. This combination medication works by improving blood sugar control, which is essential for overall health. It is often prescribed alongside diet and exercise to achieve better glycemic control.

Common effects of SYNJARDY 12.5 MG tablets may include urinary tract infections, nausea, and diarrhea. Some users might experience dizziness or headache. These effects vary and are not experienced by everyone.

SYNJARDY 12.5 MG tablets should be used with caution in individuals with kidney issues or a history of pancreatitis. It is important to follow medical advice regarding diet, exercise, and regular monitoring of blood sugar levels.

SYNJARDY 12.5 MG tablets may interact with certain medications, including insulin, other diabetes drugs, and diuretics. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects.